The goal of this clinical trial is to investigate whether early detection of bleeding and prompt blood transfusions can help prevent delirium in patients aged 75 and older who are admitted to the hospital with hip fractures. The main question the trial aims to answer is: Do patients aged 75 and older with hip fractures benefit from earlier treatment of anemia (low blood count) to reduce the risk of delirium? Researchers will compare early diagnosis and treatment of bleeding with standard care to determine if it helps lower the risk of developing delirium. Participants will: Undergo blood tests, have their vital signs monitored, and be screened for delirium three times a day for the first 48 hours after surgery. Receive blood transfusions promptly if their hemoglobin levels fall below a specified threshold. Attend a follow-up visit at 30 days to assess cognitive function and overall quality of life. Attend another follow-up at 90 days to evaluate hospital readmissions and survival.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
198
Blood transfusion is given without delay (within 4 hours) in case of hemoglobin below our threshold.
These patients recieve our standard care including blood transfusion as usual. Vital parameters and delirium screening are collected three times a day.
Aarhus University Hospital
Aarhus, Central Jutland, Denmark
NOT_YET_RECRUITINGGødstrup Hospital, Department of internal medicine
Herning, Central Jutland, Denmark
RECRUITINGNumber of Participants with Delirium
Occurence of delirium will be evaluted using screening methods three times a day.
Time frame: From enrollment to 48 hours after surgery
Change from baseline in Quality of Life
The overall Quality of life will be assed by the Overall Quality of life Depression List (OQoL-DL). It will be used to asses patients in both groups at the 30 day follow-up.
Time frame: Will be evaluated at the 30 day follow-up
Cognitive status
Short Portable Mental Status Questionnaire (SPMSQ). Sum score 0-10, higher scores indicates cognitive impariment. The SPMSQ will be used to assess cognitve status in patients in both groups at follow-up.
Time frame: Will be evaluated at the 30 day follow-up.
Readmission rate
Readmission within 90 days after surgery. Readmission is defined as any uplanned, acute rehospitalisation in this period.
Time frame: Within 90 days after surgery
90-day mortality
Mortality within the first 90-days after surgery.
Time frame: 90 days after surgery.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.